Need professional-grade analysis? Visit stockanalysis.com
$27.55B
875.74
5,386
N/A
Price Chart
Risk-Adjusted Performance
Sichuan Hebang Biotechnology Co Ltd (603077) Price Performance
Sichuan Hebang Biotechnology Co Ltd (603077) trades on SHG in CNY. The company is classified in the Basic Materials sector under the Chemicals industry. The stock currently trades at CNY3.03, down 2.88% from the previous close.
Over the past year, 603077 has traded between a low of CNY1.69 and a high of CNY3.28. The stock has gained 76.2% over this period. It is currently 7.6% below its 52-week high.
Sichuan Hebang Biotechnology Co Ltd has a market capitalization of $27.55B, with a price-to-earnings ratio of 875.74.
About Sichuan Hebang Biotechnology Co Ltd
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. The company was founded in 2002 and is based in Leshan, China.
Compare Sichuan Hebang Biotechnology Co Ltd
Side-by-side comparison against top Basic Materials peers.
Company Info
- Sector
- Basic Materials
- Industry
- Chemicals
- Exchange
- SHG
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $7.66B
- EBITDA
- $865.02M
- Profit Margin
- -1.26%
- EPS (TTM)
- -0.01
- Book Value
- 2.32
Technical Indicators
- 52 Week High
- CN¥3.54
- 52 Week Low
- CN¥1.68
- 50 Day MA
- CN¥2.77
- 200 Day MA
- CN¥2.29
- Beta
- 0.53
Valuation
- Trailing P/E
- 875.74
- Forward P/E
- N/A
- Price/Sales
- 3.60
- Price/Book
- 1.43
- Enterprise Value
- $28.61B